Bildkälla: Stockfoto

Dignitana: New agreement for distribution in Switzerland - Redeye

Redeye is favorable to the expansion of the distribution network for Switzerland and Lichtenstein by Dignitana. The older system is already present in several clinics. At the same time, the new agreement with OncoMedical will give a larger footprint in the countries mentioned above by upgrading the older system and offering the new DigniCap Delta system. We are encouraged to see that Dignitana continues to expand further and find new ways to sell new systems that will also drive consumable sales. The current agreement with OncoMedical stipulates that at least eight systems with corresponding consumables will be purchased during 2024. This news will not change our estimates but confirms our already positive stance on Dignitana. We are also content to see further sales progress outside the US, even if much attention is naturally directed there because of the market size. Dignitana will report its end-of-year numbers on 15 February.

Redeye is favorable to the expansion of the distribution network for Switzerland and Lichtenstein by Dignitana. The older system is already present in several clinics. At the same time, the new agreement with OncoMedical will give a larger footprint in the countries mentioned above by upgrading the older system and offering the new DigniCap Delta system. We are encouraged to see that Dignitana continues to expand further and find new ways to sell new systems that will also drive consumable sales. The current agreement with OncoMedical stipulates that at least eight systems with corresponding consumables will be purchased during 2024. This news will not change our estimates but confirms our already positive stance on Dignitana. We are also content to see further sales progress outside the US, even if much attention is naturally directed there because of the market size. Dignitana will report its end-of-year numbers on 15 February.
Börsvärldens nyhetsbrev
ANNONSER